Dataset Information

A CRISPR/Cas9-based enhancement of high-throughput single-cell transcriptomics

ABSTRACT: Single-cell RNA-seq (scRNAseq) struggles to capture the cellular heterogeneity of transcripts within individual cells due to the prevalence of highly abundant and ubiquitous transcripts, which obscure the detection of biologically distinct transcripts expressed at up to several orders of magnitude lower levels. To address this challenge, we introduce single-cell CRISPRclean (scCLEAN), a molecular method that globally recomposes scRNAseq libraries, providing a benefit that cannot be recapitulated with deeper sequencing. scCLEAN utilizes the programmability of CRISPR/Cas9 to target and remove less than 1% of the transcriptome while redistributing approximately half of reads, shifting the focus toward less abundant transcripts. We then experimentally apply scCLEAN to both heterogeneous immune cells and homogenous vascular smooth muscle cells to demonstrate its ability to uncover novel biological signatures in different biological contexts. We further emphasize scCLEAN’s versatility by applying it to a third-generation sequencing method, single-cell MAS-Seq, to increase transcript-level detection and discovery. Here we show, the projected utility of scCLEAN across a wide array of human tissues and cell types, indicating which contexts this technology proves beneficial and those in which its application is not advisable.

ORGANISM(S): Homo sapiens

PROVIDER: GSE283554 | GEO | 2024/12/19

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Androgen deprivation therapy has improved patient survival. Nevertheless, treatment resistance inevitably emerges due to the complex interplay of tumor heterogeneity and lineage plasticity. We integrated scRNAseq data from multiple studies, comprising both publicly available cohorts and data generated by our research team, and established the HuPSA (Human Prostate Single cell Atlas) and MoPSA (Mouse Prostate Single cell Atlas) datasets. Through unsupervised clustering and manual annotation, we found that both atlases consisted of previously known cell clusters including prostate adenocarcinoma (AdPCa), neuroendocrine prostate cancer (NEPCa), stromal, and immune cell populations. Our analysis also unearthed the less described populations including MMP7+ prostate club cells and two novel lineage plastic cancerous populations, namely Progenitor-like and KRT7. Immunohistochemical staining analysis confirmed the presence of these populations in both human and mouse PCa tissues, reinforcing their significance in PCa pathobiology. Furthermore, employing HuPSA based deconvolution, we scrutinized 877 high-quality human PCa bulk RNAseq samples and reclassified them into different molecular subtypes, including the newly discovered KRT7 and Progenitor-like categories. Moreover, employing supervised dimensional reduction and label transferring techniques, we projected the scRNAseq data derived from C4-2B xenograft tumors onto HuPSA. Our analysis effectively identified the diverse subpopulations within the tumor, including C4-2B derived AdPCa and NEPCa cells as well as the murine cells in the tumor microenvironment. We launched the “PCaAtlas” app (https://pcatools.shinyapps.io/ProAtlas_dev/) for users to visualize genes expression in re-classified human prostatic tissue samples. In conclusion, our study has successfully integrated multiple scRNAseq datasets and made these data easily accessible to researchers. Our results elucidate a roadmap of PCa progression, showcasing the development of heterogeneous populations and the involvement of lineage plasticity. This understanding holds promise for guiding the development of precision medicine in PCa field. Additionally, the HuPSA and MoPSA provide invaluable blueprints for analyzing and interpreting user-generated PCa single-cell RNAseq data.

Dataset Information

A CRISPR/Cas9-based enhancement of high-throughput single-cell transcriptomics

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets